Get the Stockscreener App
0.0855
0.83%
0.0007
Enzon Pharmaceuticals Inc Stock (ENZN) Forecast
The Enzon Pharmaceuticals Inc (ENZN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.1026, representing a +20.05% increase from the current price of $0.0855. The highest analyst price target is $0.1034, and the lowest is $0.1018.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENZN Price Target
Average 0.1697
(+98.46% Upside)
Long-term ENZN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enzon Pharmaceuticals Inc financial reports and earnings history, Enzon Pharmaceuticals Inc (ENZN) stock could reach $0.8961 by 2030, $2.1659 by 2040 and $3.8966 by 2050. See the projected annual prices until 2050 of the Enzon Pharmaceuticals Inc stock below:
- Enzon Pharmaceuticals Inc (ENZN) is expected to reach an average price of $1.5657 in 2035, with a high prediction of $1.6211 and a low estimate of $1.5757. This indicates an $1,731% rise from the last recorded price of $0.0855.
- Enzon Pharmaceuticals Inc (ENZN) stock is projected to chart a bullish course in 2040, with an average price target of $2.0707, representing an $2,322% surge from its current level. The forecast ranges from a conservative $2.0804 to a sky-high $2.1659.
- Our analysts predict Enzon Pharmaceuticals Inc (ENZN) to jump 3,766% by 2045, soaring from $3.3062 to an average price of $3.3051, potentially reaching $3.393. While $3.3062 is the low estimate, the potential upside is significant.
- Enzon Pharmaceuticals Inc (ENZN) stock is expected to climb by 2050, reaching an average of $3.7525, a $4,289% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.8966 and $3.7725, respectively, highlighting the market's uncertainty.
Enzon Pharmaceuticals Inc Stock (ENZN) Year by Year Forecast
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2025
Enzon Pharmaceuticals Inc Stock (ENZN) is expected to reach an average price of $0.1057 in 2025, with a high prediction of $0.1877 and a low estimate of $0.0237. This indicates an +23.61% rise from the last recorded price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.0992 | $0.1018 | $0.1034 | +16.07% |
| July, 2025 | $0.0774 | $0.0824 | $0.09 | -9.43% |
| August, 2025 | $0.1043 | $0.0871 | $0.1617 | +21.97% |
| September, 2025 | $0.1874 | $0.1673 | $0.1877 | +119.16% |
| October, 2025 | $0.1852 | $0.1839 | $0.1781 | +116.59% |
| November, 2025 | $0.1706 | $0.1655 | $0.1753 | +99.51% |
| December, 2025 | $0.1411 | $0.146 | $0.1657 | +65.01% |
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2026
The predicted value for Enzon Pharmaceuticals Inc (ENZN) in 2026 is set at an average of $0.2616. Estimates vary from a peak of $0.382 to a trough of $0.1412, indicating an +205.95% surge from the present price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2152 | $0.1412 | $0.2351 | +151.70% |
| February, 2026 | $0.2875 | $0.2154 | $0.2521 | +236.28% |
| March, 2026 | $0.2485 | $0.2517 | $0.2569 | +190.67% |
| April, 2026 | $0.2191 | $0.2291 | $0.2403 | +156.28% |
| May, 2026 | $0.2117 | $0.2217 | $0.2279 | +147.57% |
| June, 2026 | $0.326 | $0.1999 | $0.3086 | +281.24% |
| July, 2026 | $0.3383 | $0.2875 | $0.2931 | +295.63% |
| August, 2026 | $0.3423 | $0.3196 | $0.3262 | +300.30% |
| September, 2026 | $0.297 | $0.3181 | $0.311 | +247.36% |
| October, 2026 | $0.2839 | $0.2928 | $0.2902 | +232.00% |
| November, 2026 | $0.2656 | $0.2587 | $0.2725 | +210.63% |
| December, 2026 | $0.3454 | $0.3595 | $0.382 | +303.98% |
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enzon Pharmaceuticals Inc (ENZN) is $0.4256, with a high forecast of $0.5339 and a low forecast of $0.3174. This indicates an +397.83% increase from the last price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.393 | $0.3983 | $0.3954 | +359.65% |
| February, 2027 | $0.3824 | $0.3874 | $0.3774 | +347.25% |
| March, 2027 | $0.3524 | $0.3564 | $0.3704 | +312.17% |
| April, 2027 | $0.3194 | $0.3244 | $0.3404 | +273.57% |
| May, 2027 | $0.3924 | $0.3174 | $0.4554 | +358.99% |
| June, 2027 | $0.4716 | $0.4526 | $0.4646 | +451.63% |
| July, 2027 | $0.4478 | $0.4552 | $0.4559 | +423.79% |
| August, 2027 | $0.4223 | $0.42 | $0.4354 | +393.97% |
| September, 2027 | $0.3867 | $0.3964 | $0.4146 | +352.33% |
| October, 2027 | $0.5463 | $0.3761 | $0.5289 | +538.92% |
| November, 2027 | $0.5673 | $0.5036 | $0.5318 | +563.49% |
| December, 2027 | $0.5437 | $0.5231 | $0.5339 | +535.88% |
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2028
In 2028, Enzon Pharmaceuticals Inc (ENZN) is projected to reach an average price of $0.5553, with a high projection of $0.6758 and a low estimate of $0.4349. This indicates an +549.50% rise from the last price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4737 | $0.4837 | $0.5103 | +454.01% |
| February, 2028 | $0.455 | $0.4651 | $0.4769 | +432.20% |
| March, 2028 | $0.4383 | $0.4349 | $0.4417 | +412.61% |
| April, 2028 | $0.5594 | $0.5756 | $0.6023 | +554.29% |
| May, 2028 | $0.5814 | $0.5909 | $0.6031 | +580.02% |
| June, 2028 | $0.5655 | $0.5855 | $0.5767 | +561.43% |
| July, 2028 | $0.53 | $0.54 | $0.5484 | +519.91% |
| August, 2028 | $0.4886 | $0.4936 | $0.5159 | +471.49% |
| September, 2028 | $0.6086 | $0.4934 | $0.6758 | +611.77% |
| October, 2028 | $0.6672 | $0.6667 | $0.6724 | +680.31% |
| November, 2028 | $0.6454 | $0.6554 | $0.6432 | +654.81% |
| December, 2028 | $0.6112 | $0.611 | $0.6306 | +614.81% |
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2029
The 2029 price forecast for Enzon Pharmaceuticals Inc Stock (ENZN) is $0.6871 on average, with a high prediction of $0.8226 and a low estimate of $0.5515. This represents an +703.57% increase from the previous price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5572 | $0.5621 | $0.6014 | +551.65% |
| February, 2029 | $0.7244 | $0.5515 | $0.7492 | +747.23% |
| March, 2029 | $0.7771 | $0.7197 | $0.7417 | +808.89% |
| April, 2029 | $0.7136 | $0.7266 | $0.7416 | +734.62% |
| May, 2029 | $0.6646 | $0.6746 | $0.6963 | +677.31% |
| June, 2029 | $0.6376 | $0.6476 | $0.6636 | +645.68% |
| July, 2029 | $0.84 | $0.6095 | $0.8226 | +882.50% |
| August, 2029 | $0.8327 | $0.7917 | $0.7876 | +873.97% |
| September, 2029 | $0.7849 | $0.7944 | $0.8116 | +818.06% |
| October, 2029 | $0.7474 | $0.7684 | $0.776 | +774.12% |
| November, 2029 | $0.7146 | $0.7246 | $0.7267 | +735.84% |
| December, 2029 | $0.683 | $0.6675 | $0.6984 | +698.79% |
Enzon Pharmaceuticals Inc Stock (ENZN) Price Forecast for 2030
Enzon Pharmaceuticals Inc Stock (ENZN) is expected to reach an average price of $0.8843 in 2030, with a high forecast of $1.043 and a low forecast of $0.7256. This signifies an +934.24% surge from the last price of $0.0855.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8448 | $0.8638 | $0.8961 | +888.05% |
| February, 2030 | $0.8728 | $0.8781 | $0.8815 | +920.80% |
| March, 2030 | $0.8426 | $0.8526 | $0.8438 | +885.48% |
| April, 2030 | $0.7881 | $0.8019 | $0.8257 | +821.73% |
| May, 2030 | $0.7355 | $0.7404 | $0.7712 | +760.21% |
| June, 2030 | $0.9426 | $0.7256 | $0.9695 | +1,002% |
| July, 2030 | $0.9563 | $0.9358 | $0.9515 | +1,019% |
| August, 2030 | $0.9129 | $0.9301 | $0.9357 | +967.74% |
| September, 2030 | $0.8629 | $0.8655 | $0.8935 | +909.27% |
| October, 2030 | $0.8077 | $0.8174 | $0.8503 | +844.71% |
| November, 2030 | $1.0604 | $0.7836 | $1.043 | +1,140% |
| December, 2030 | $1.0569 | $1.0079 | $1.0214 | +1,136% |
9.37%
0.85%
Cap:
|
Volume (24h):